Novel inhaled PI3Kdelta inhibitor with improved properties for respiratory disease treatment Dec. 7, 2018
Multidomain antibodies with breadth and potency protect mice from a wide array of influenza strains Dec. 7, 2018
Topline results presented from ENCORE-PH phase IIb study in patients with NASH cirrhosis Dec. 7, 2018
Icagen and Roche collaborate to develop and commercialize therapy for neurological diseases Dec. 7, 2018
GMI-1687, a novel inhibitor of E-selectin with promising activity in preclinical models of AML Dec. 7, 2018
RSS